We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Avastin Sees Positive Results in Trials for Ovarian Cancer
Avastin Sees Positive Results in Trials for Ovarian Cancer
February 16, 2011
Roche’s Avastin (bevacizumab) met its primary endpoint of significant progression-free survival (PFS) in a Phase III clinical trial involving women with previously treated ovarian cancer.